drugset / Trial / NCT02740829
Assessment of Intranasal Glucagon on Endogenous Glucose Production
RandomizedParallel-groupSingle-blindTreatment
Summary
Peripheral glucagon action increases hepatic glucose production. In rodents hypothalamic action of glucagon paradoxically suppresses glucose production. Intranasally administered peptides have been shown to preferentially enter the central nervous system. We assessed the effects of intranasal glucagon on hepatic glucose production
Timeline
- Start
- 2015-03
- Primary completion
- 2016-01
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glucagon | Peptide | 1 mg | Intranasal |